GlaxoSmithKline to close Sligo plant

Up to 250 jobs are to go in Sligo with the closure of Stiefel Laboratories.

The facility, which was bought by GlaxoSmithKline in July, is to cease operations after a global review by GSK found under-utilised capacity.

The plant, which makes skin products, will be closed by the end of 2013, by which time production of all products is being transferred to alternative facilities.